Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four genes that could help diagnose severe alopecia areata early.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Early intervention and patient education are crucial for managing alopecia areata.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

A protein from certain immune cells is key for new hair growth after skin injury in mice.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Fullerenes show potential in skin care but need more safety research.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.